These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 12408773)

  • 21. [Comparison of therapeutic effects between transcatheter arterial chemoembolization and transcatheter arterial-portal venous double chemoembolization in treatment of moderate and advanced stages of primary liver carcinoma].
    Wu YP; Zhang WZ; Li L; Guo RP; Xie CM; Cai PQ
    Ai Zheng; 2003 Aug; 22(8):880-3. PubMed ID: 12917041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transcatheter arterial chemoembolization combined with external radiation for primary liver cancer].
    Guo W; Song M; Yu E
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):25-8. PubMed ID: 11776790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB; Wang JH; Yan ZP; Qian S; Liu R
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP; Yu WS; Wei W
    Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of combinated transcatheter hepatic artery chemoembolization and factors affecting the prognosis in patients with primary hepatic carcinoma].
    Li CX; Zhang Y; Gao L
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):942-5. PubMed ID: 17533749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
    Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
    Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
    Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study on transcatheter arterial chemoembolization, portal vein embolization and high intensity focused ultrasound sequential therapy for patients.
    Cui L; Liu XX; Jiang Y; Wu XJ; Liu JJ; Zhou XR; He XJ; Huang XE
    Asian Pac J Cancer Prev; 2012; 13(12):6257-61. PubMed ID: 23464441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization].
    Huang JH; Wu PH; Gu YK; Zhang FJ; Li CX; Gao F; Zhang L; Fan WJ; Li CJ
    Ai Zheng; 2006 Aug; 25(8):1003-6. PubMed ID: 16965683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effect of transcatheter arterial chemoembolization and percutaneous injection of acetic acids on primary liver cancer.
    Chen HB; Huang Y; Dai DL; Zhang X; Huang ZW; Zhang QK; Wang HH; Zhang JS; Pan G
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):55-7. PubMed ID: 14969838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
    Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous transarterial and portal embolization for unresectable tumors of the liver.
    Di Carlo I; Pulvirenti E; Toro A; Patanè D
    Hepatogastroenterology; 2010; 57(97):140-5. PubMed ID: 20422890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
    Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M
    Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study.
    Yan JJ; Shen F; Wang K; Wu MC
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):183-6. PubMed ID: 14607735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization.
    Zhang XB; Wang JH; Yan ZP; Qian S; Du SS; Zeng ZC
    Cancer; 2009 Mar; 115(6):1245-52. PubMed ID: 19156918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M; Wu PH; Zeng YX; Xia JC; Zhang FJ; Xian LJ; Zhang YP; Zhou K; Fan WJ; Zhang L; Gao F; Zhou QM
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1823-8. PubMed ID: 17054858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma].
    Wang QX; Yan JJ; Zhou FG; Shen J; Yan YQ
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):748-51. PubMed ID: 19615209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.